2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.

The MarketWatch News Department was not involved in the creation of this content. CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ -- Suvoda (recently merged under common ownership with Greenphire), a ...

Clinical research sites face an information challenge that hinders efficiency and collaboration. As trial complexity increases, the multiple logins, devices, and spreadsheets site staff use to execute ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...

Successful clinical trial conduct balances participant safety, treatment efficacy and operational feasibility. But slow patient identification and enrollment, cost overruns and missed deadlines pose a ...

ICON’s June 2025 survey of more than 100 investigators and site leaders reveals persistent bottlenecks in study startup driven by contract and budget delays, slow activation timelines, and ...

Investigators from UB’s Clinical and Translational Science Institute (CTSI) were among those from several institutions who were recently awarded a two-year, $2.1 million grant from NCATS (National ...

Headlands Research has opened its fifth and final research site under its multi-year partnership with Pfizer to increase the diversity of participants in clinical trials, the clinical research network ...

PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...

CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ -- Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions to ...